المؤلفون: Oberic L., Peyrade F., Puyade M., BONNET, Christophe, Dartigues-Cuillères P., Fabiani B., Ruminy P., Maisonneuve H., Abraham J., Thieblemont C., Feugier P., Salles G., Bijou F., Pica GM., Damaj G., Haioun C., Casasnovas RO., Farhat H., Le Calloch R., Waultier-Rascalou A., Malak S., Paget J., Gat E., Tilly H., Jardin F.

المصدر: Journal of Clinical Oncology, 39, 1203-1213 (2021)

مصطلحات موضوعية: Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

Relation: urn:issn:0732-183X; urn:issn:1527-7755

URL الوصول: https://orbi.uliege.be/handle/2268/256117

المؤلفون: Pica, Gm, Nati, S, Vitolo, U, Botto, B, Galimberti, Sara, Zinzani, Pl, Cascavilla, N, Petrini, Mario, Carella, A. M.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3728::910e1f44466ede79198d9a1d5e1019c0
http://hdl.handle.net/11568/151753

المؤلفون: Decaux O; INSERM, Établissement Français du Sang de Bretagne, Unité Mixte de Recherche (UMR) S1236, Université de Rennes 1, Rennes, France.; Service d'Hématologie Clinique, Centre Hospitalier Universitaire, Rennes, France., Fontan J; Department of Hematology, Centre Hospitalier Régional et Universitaire de Besançon, Besançon, France., Perrot A; CHU de Toulouse, IUCT-O, Service d'Hématologie, UPS, Université de Toulouse, Toulouse, France., Karlin L; Hematology Department, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Benite, France., Touzeau C; Department of Hematology, University Hospital of Nantes, Nantes, France., Schulmann S; Hématologie, CHRU Hôpitaux de Brabois, Nancy, France., Manier S; Maladie du sang, CHRU Hôpital Claude Huriez, Lille, France., Belhadj K; Unité Hémopathies Lymphoïdes, Centre Hospitalier Universitaire Henri Mondor, Créteil, France., Trebouet A; Department of Haematology, Bretagne Sud Hospital Centre, Lorient, France., Zunic P; Department of Haematology, University Hospital Centre, Saint-Pierre, France., Schiano De Colella JM; Department of Hematology, Institut Paoli Calmettes, Marseille, France., Castel B; Service de Médecine Interne, Centre Hospitalier de Bigorre, Tarbes, France., Van De Wyngaert Z; Sorbonne Université, AP-HP, Centre de Recherche Saint-Antoine INSERM UMRs938, Service D'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France., Pica GM; Hématologie, Centre Hospitalier Métropole Savoie, Chambéry, France., Tiab M; Médecine Interne, CHU Vendée, La Roche sur Yon, France., Kuhnowski F; Department of Hematology, Institut Curie, Paris, France., Bouketouche M; Oncologie et hématologie, Centre Hospitalier de Saint-Quentin, Saint-Quentin, France., Rigaudeau S; Service d'Hématologie Clinique, Centre Hospitalier de Versailles André Mignot, Faculté de Médecine Xavier Bichat, Université Paris Diderot, Paris, France., Benramdane R; Department of Hematology, Centre Hospitalier Pontoise René Dubos, Pontoise, France., Tekle C; Sanofi, Cambridge, Massachusetts, USA., Lafore R; Sanofi, Gentilly, France., Gaucher M; Sanofi, Gentilly, France., Corre J; IUC-T Oncopole, Unité de Génomique du Myélome, Toulouse, France., Leleu X; Faculte de médecine, INSERM CIC 1402 and U 1313, Centre Hospitalier Universitaire (CHU), Poitiers, France.

المصدر: European journal of haematology [Eur J Haematol] 2024 Sep; Vol. 113 (3), pp. 290-297. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/mortality , Multiple Myeloma*/diagnosis , Dexamethasone*/administration & dosage , Dexamethasone*/therapeutic use , Dexamethasone*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Thalidomide*/analogs & derivatives , Thalidomide*/administration & dosage , Thalidomide*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects, Humans ; Retrospective Studies ; Male ; Female ; Aged ; Middle Aged ; Treatment Outcome ; Drug Resistance, Neoplasm ; Adult ; Aged, 80 and over ; Recurrence

المؤلفون: Camus V; Department of Hematology, Centre Henri Becquerel, Rouen, France., Thieblemont C; Hematology Department, Hospital Saint-Louis, Paris, France., Gaulard P; Department of Pathology and InsermU955, University Hospital Henri Mondor, Créteil, France., Cheminant M; Service d'Hematologie adultes, Hopital Universitaire Necker Enfants Malades, AP-HP, Paris, France., Casasnovas RO; Department of Hematology, CHU Dijon-Bourgogne and INSERM 1231, Dijon, France., Ysebaert L; IUCT Oncopole, Toulouse, France., Damaj GL; CHU de Caen Normandie, Normandie, France., Guidez S; Service d'Hématologie, CHU de Poitiers, Poitiers, France., Pica GM; Department of Hematology, Centre Hospitalier Métropole Savoie Chambéry, Chambéry, France., Kim WS; Samsung Medical Center, Seoul, South Korea., Lim ST; National Cancer Centre Singapore, Singapore., Andre M; Department of Hematology, CHU UCL Namur, Yvoir, Belgium., Gutiérrez N; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Penarrubia MJ; Hospital Clinico Universitario de Valladolid, Valladolid, Spain., Staber PB; Division of Hematology, Department of Medicine I, Medical University Vienna, Vienna, Austria., Trotman J; Concord Repatriation General Hospital, University of Sydney, Concord, Australia., Hüttmann A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Stefoni V; Policlinico Sant'Orsola-Malpighi, Bologna, Italy., Tucci A; Hematology Division, Spedali Civili di Brescia, Brescia, Italy., Fogarty P; Biostatistics Department, LYSARC, Hôpital Lyon-Sud, Pierre-Bénite, France., Farhat H; Department of Oncology-Hematology, Centre Hospitalier de Versailles, Le Chesnay, France., Abraham J; Department of Hematology, Centre Hospitalo-universitaire (CHU) Dupuytren, Limoges, France., Abarah W; Department of Hematology, Grand Hôpital de l'Est Francilien, Meaux, France., Belmecheri F; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Ribrag V; Department of Hematology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Delfau-Larue MH; Department of Immunobiology and InsermU955, University Hospital Henri Mondor, Créteil, France., Cottereau AS; Department of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Cité University, Paris, France., Itti E; Department of Nuclear Medicine, CHU Henri Mondor, Créteil, France., Li J; Bristol Myers Squibb Company, Princeton, NJ., Delarue R; Service d'Hematologie adultes, Hopital Universitaire Necker Enfants Malades, AP-HP, Paris, France., de Leval L; Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland., Morschhauser F; Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France., Bachy E; Hospices Civils De Lyon, Lyon, France.; Claude Bernard Lyon 1 University, Lyon, France.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 10; Vol. 42 (14), pp. 1612-1618. Date of Electronic Publication: 2024 Feb 16.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/drug therapy , Lymphoma, T-Cell, Peripheral*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Cyclophosphamide*/administration & dosage , Cyclophosphamide*/therapeutic use , Doxorubicin*/administration & dosage , Doxorubicin*/therapeutic use , Vincristine*/administration & dosage , Vincristine*/therapeutic use , Prednisone*/administration & dosage , Prednisone*/therapeutic use , Depsipeptides*/administration & dosage , Depsipeptides*/therapeutic use, Humans ; Middle Aged ; Male ; Female ; Aged ; Adult ; Progression-Free Survival

SCR Protocol: CHOP protocol

المؤلفون: Ghesquières H; Department of Hematology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France., Cherblanc F; Lymphoma Academic Research Organisation, Hopital Lyon Sud, Pierre Benite, France., Belot A; Lymphoma Academic Research Organisation, Hopital Lyon Sud, Pierre Benite, France., Micon S; Roche SAS, Boulogne-Billancourt, France., Bouabdallah KK; Hematology and Cell Therapy Department, University Hospital of Bordeaux, Bordeaux, France., Esnault C; Roche SAS, Boulogne-Billancourt, France., Fornecker LM; Institut de Cancérologie Strasbourg Europe (ICANS) and University of Strasbourg, Strasbourg, France., Thokagevistk K; Roche SAS, Boulogne-Billancourt, France., Bonjour M; Lymphoma Academic Research Organisation, Hopital Lyon Sud, Pierre Benite, France., Bijou F; Department of Hematology, Institut Bergonie, Bordeaux, France., Haioun C; Lymphoid Malignancies Unit, Assistante Publique Hôpitaux de Paris APHP, Hopital Henri Mondor, Creteil, France., Morineau N; Department of Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France., Ysebaert L; Institut universitaire du cancer de Toulouse Oncopole, Toulouse, France., Damaj G; Hematology Institute of Basse Normandie, Centre Hospitalier Universitaire de Caen, Caen, France., Tessoulin B; Department of Hematology, Centre Hospitalier Universitaire de Nantes, Nantes, France., Guidez S; Department of Hematology, Centre Hospitalier Universitaire de Poitiers, Poitiers, France., Morschhauser F; Department of Hematology, Universite de Lille, Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Thiéblemont C; Université Paris Cité, Assistante Publique Hôpitaux de Paris, Hôpital Saint-Louis, Service d'Hémato-Oncologie, Paris, France., Chauchet A; Department of Hematology, Centre Hospitalier Universitaire de Besançon, Besançon, France., Gressin R; Department of Hematology, Centre Hospitalier Universitaire de Grenoble, Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France., Jardin F; Department of Clinical Hematology, INSERM U1245 Unit, Centre Henri Becquerel, Rouen, France., Fruchart C; Department of Hematology, Centre Hospitalier de Dunkerque, Dunkirk, France., Labouré G; Deparment of Hematology, Centre Hospitalier de Libourne, Libourne, France., Fouillet L; Department of Hematology, Centre Hospitalier Universitaire de Saint Etienne, Saint Etienne, France., Lionne-Huyghe P; Department of Hematology, Centre Hospitalier d'Arras, Arras, France., Bonnet A; Department of Hematology, Centre Hospitalier de Bretagne Atlantique, Vannes, France., Lebras L; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Amorim S; Department of Hematology, Hopital Saint Vincent de Paul, Lille, France., Leyronnas C; Department of Hematology, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France., Olivier G; Department of Hematology, Centre Hospitalier de Niort, Niort, France., Guieze R; Department of Hematology, Centre Hospitalier Universitaire de Clermont Ferrand, Clermont Ferrand, France., Houot R; Department of Hematology, Centre Hospitalier Universitaire de Rennes, Rennes, France., Launay V; Department of Hematology, Centre Hospitalier de Saint Brieuc, Saint Brieuc, France., Drénou B; Department Hematology, Groupe Hospitalier Mulhouse Sud Alsace, Mulhouse, France., Fitoussi O; Department of Hematology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France., Detourmignies L; Department of Hematology, Centre Hospitalier de Roubaix, Roubaix, France., Abraham J; Department of Hematology, Centre Hospitalier Universitaire de Limoges, Limoges, France., Soussain C; Department of Hematology, Institut Curie, Saint-Cloud, France., Lachenal F; Department of Hematology, Centre Hospitalier Pierre Oudot, Bourgoin-Jallieu, France., Pica GM; Department of Hematology, Centre Hospitalier Metropole Savoie, Chambery, France., Fogarty P; Lymphoma Academic Research Organisation, Hopital Lyon Sud, Pierre Benite, France., Cony-Makhoul P; Lymphoma Academic Research Organisation, Hopital Lyon Sud, Pierre Benite, France., Bernier A; Lymphoma Academic Research Organisation, Hopital Lyon Sud, Pierre Benite, France., Le Guyader-Peyrou S; Registre des Hémopathies Malignes de la Gironde, Institut Bergonié, University of Bordeaux, Inserm, Team EPICENE, Bordeaux, France., Monnereau A; Registre des Hémopathies Malignes de la Gironde, Institut Bergonié, University of Bordeaux, Inserm, Team EPICENE, Bordeaux, France., Boissard F; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Rossi C; Department of Hematology, Centre Hospitalier Universitaire de Dijon Bourgogne, Dijon, France., Camus V; Department of Clinical Hematology, INSERM U1245 Unit, Centre Henri Becquerel, Rouen, France.

المصدر: Blood advances [Blood Adv] 2024 Jan 23; Vol. 8 (2), pp. 296-308.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Lymphoma, Large B-Cell, Diffuse*/diagnosis , Lymphoma, Large B-Cell, Diffuse*/drug therapy, Adult ; Humans ; Aged ; Prospective Studies ; Retrospective Studies ; Rituximab/therapeutic use ; Cyclophosphamide/therapeutic use ; Prednisone/therapeutic use ; Vincristine/therapeutic use ; Doxorubicin/therapeutic use

المؤلفون: Talbot A; Hôpital Saint Louis, APHP, Immuno-Hématologie, INSERM U976, équipe 5. alexis.talbot.fr@gmail.com., Bobin A; CHU de Poitiers, Service d'Hématologie et Thérapie cellulaire, CIC U1402, Poitiers., Tabone L; IFM Intergroupe Francophone du Myélome., Lambert J; ECSTRA, Centre de Recherche en Epidémiologie et Statistiques, INSERM UMR 1153., Boccaccio C; IFM Intergroupe Francophone du Myélome., Deal C; IFM Intergroupe Francophone du Myélome., Petillon MO; Hôpital Claude Huriez, Hématologie, Lille., Allangba O; Centre Hospitalier Yves Le Foll, Hématologie-Oncologie, Saint Brieuc., Agape P; Centre hospitalier de Laval, Hématologie, Laval., Arnautou P; Hôpital d'Instruction des Armées Percy, Hématologie, Clamart., Belkhir R; APHP Bicêtre, Rhumatologie, Kremlin-Bicetre., Cailleres S; Centre Hospitalier du Pays d'Aix, Service hématologie oncologie, Aix-enProvence., Chaoui D; Centre Hospitalier Victor Dupouy, Hématologie, Argenteuil., Chrétien ML; CHU Dijon Bourgogne, Hématologie, Dijon., Decaux O; CHRU Hôpital de Pontchaillou, Hématologie, Rennes., Schulmann S; CHRU Hôpitaux de Brabois, Hématologie, Nancy., Frenzel L; APHP, Hôpital Universitaire Necker Enfants Malades, Hématologie adultes., Gastaud L; Centre Antoine Lacassagne, service onco-hématologie, Nice., Huart A; CHU Toulouse - Hôpital de Rangueil, Néphrologie, Toulouse., Hulin C; CHU Bordeaux, Hématologie et thérapie cellulaire, Bordeaux., Karlin L; Centre Hospitalier Lyon Sud, Hématologie, Lyon Sud., Laribi K; Centre Hospitalier du Mans, Hématologie clinique, Le Mans., Le Calloch R; Centre Hospitalier de Quimper Cornouaille, Service d'hématologie, Quimper., Lenain P; Centre Henri Becquerel, Hématologie, Rouen., Macro M; CHU Caen, Hématologie, Caen., Manier S; CHRU Hôpital Claude Huriez, Maladie du sang, Lille., Montes L; CHU Amiens, Hématologie Clinique, Amiens., Moreau S; CHU de Limoges, Hématologie clinique et thérapie cellulaire, Limoges., Moreau P; CHU de Nantes - Hôtel Dieu, Hématologie clinique, Nantes., Morel V; APHP Pitié-Salpêtrière, Hématologie Clinique., Norwood J; Hôpital du Scorff, Hématologie, Lorient., Piocelle FO; CH Annecy Genevois, Hématologie, Annecy., Perrot A; CHU de Toulouse, IUCT-O, Service Hématologie, Université de Toulouse UPS, Toulouse., Pica GM; Centre Hospitalier Métropole Savoie, Hématologie, Chambéry., Rey P; Centre Léon Bérard, Onco-Hématologie, Lyon CAC., Schmitt A; Bordeaux Unicancer, Onco-Hématologie, Bordeaux., Stoppa AM; IPC Unicancer Marseille, Hématologie, Marseille., Tiab M; CHD Vendée, Médecine Interne, La Roche-sur-Yon., Touzeau C; CHU de Nantes - Hôtel Dieu, Hématologie clinique, Nantes., Vidal V; APHP Avicenne, Hématologie Clinique., Vignon M; APHP Cochin, Hématologie clinique., Vincent L; CHU Montpellier - Hôpital Saint Eloi, Hématologie, Montpellier., Van De Wyngaert Z; APHP Saint Antoine, Hématologie clinique et thérapie cellulaire., Zarnitsky C; Hôpital Jacques Monod, Rhumatologie, Le Havre., Kerbouche N; GSK (GlaxoSmithKline)., Paka P; GSK (GlaxoSmithKline)., Leleu X; CHU de Poitiers, Service d'Hématologie et Thérapie cellulaire, CIC U1402, Poitiers., Arnulf B; Hôpital Saint Louis, APHP, Immuno-Hématologie, INSERM U976, équipe 5., Avet-Loiseau H; IUC-T Oncopole, Unité de Génomique du Myélome, Toulouse, France., Du Myélome IIF

المصدر: Haematologica [Haematologica] 2023 Oct 01; Vol. 108 (10), pp. 2774-2782. Date of Electronic Publication: 2023 Oct 01.

نوع المنشور: Observational Study; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy, Adult ; Humans ; Aged ; Treatment Outcome ; Retrospective Studies ; France

المؤلفون: Cartron G; Department of Hematology, UMR CNRS 5535, University Hospital, Montpellier, France., Bachy E; Department of Hematology, University Hospital, Lyon, France., Tilly H; Department of Hematology, U1245, Henri Becquerel Institute, Rouen, France., Daguindau N; Departement of Hematology, Annecy-Genevois Hospital Centre, Annecy, France., Pica GM; Departement of Hematology, Hospital Centre, Chambery, France., Bijou F; Departement of Hematology, Bergonié Institute, Bordeaux, France., Mounier C; Departement of Hematology, Oncology and Hematology Institute, Sainte-Etienne, France., Clavert A; Departement of Hematology, University Hospital, Angers, France., Damaj GL; Departement of Hematology, University Hospital, Caen, France., Slama B; Departement of Hematology, Hospital Centre, Avignon, France., Casasnovas O; Departement of Hematology, University Hospital, Dijon, France., Houot R; Departement of Hematology, University Hospital, Rennes, France., Bouabdallah K; Departement of Hematology, University Hospital, Bordeaux, France., Sibon D; Departement of Hematology, Necker Hospital, APHP, Paris, France., Fitoussi O; Departement of Hematology, Polyclinic Bordeaux Nord, Bordeaux, France., Morineau N; Departement of Hematology, Hospital Centre, La Roche-sur-Yon, France., Herbaux C; Department of Hematology, UMR CNRS 5535, University Hospital, Montpellier, France., Gastinne T; Departement of Hematology, University Hospital, Nantes, France., Fornecker LM; Departement of Hematology, University Hospital, Strasbourg, France., Haioun C; Departement of Hematology, Lymphoma Malignancies Unit, Henri Mondor Hospital, APHP, Créteil, France., Launay V; Departement of Hematology, Hospital Centre, Saint-Brieuc, France., Araujo C; Departement of Hematology, Hospital Centre, Bayonne, France., Benbrahim O; Departement of Hematology, Hospital Centre, Orléans, France., Sanhes L; Departement of Hematology, Hospital Centre, Perpignan, France., Gressin R; Departement of Hematology, University Hospital, Grenoble, France., Gonzalez H; Departement of Hematology, Hospital Centre, Pontoise, France., Morschhauser F; Department of Hematology, ULR 7365 GRITA, University Hospital, Lille, France., Ternant D; UMR7292, University François-Rabelais, Tours, France., Xerri L; Department of Biopathology, Paoli-Calmettes Institue, Marseille, France., Tarte K; UMR1236, Department of Immunology, Rennes I University, Rennes, France., Pranger D; Department of Haematology, Hospital Centre, Charleroi, Belgium.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jul 01; Vol. 41 (19), pp. 3523-3533. Date of Electronic Publication: 2023 Apr 18.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Follicular*/pathology, Humans ; Rituximab ; Tumor Burden ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Progression-Free Survival

المؤلفون: Anota A; Centre Léon Bérard, Department of Clinical Research and Innovation & Human and Social Sciences Department & French National Platform Quality of Life and Cancer, Lyon, France., Basset M; Centre Léon Bérard, Department of Clinical Research and Innovation, Lyon, France., Belot A; LYSARC, Hôpital Lyon Sud, Pierre Bénite, France., Bascoul-Mollevi C; Institute Desbrest of Epidemiology and Public Health, Montpellier University Hospital, University of Montpellier, INSERM, Montpellier, France., Cottone F; Italian Group for Adult Hematologic Diseases (GIMEMA) Data Center and Health Outcomes Research Unit, Rome, Italy., Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA) Data Center and Health Outcomes Research Unit, Rome, Italy., Préau M; Inserm 1296, Université Lyon 2, Lyon, France., Touraine C; Cancer Institute of Montpellier, Montpellier, France., Damaj G; Institut d'Hématologie de Basse Normandie, Service Hématologie, Caen, France., Guidez S; CHU de Poitiers - Hôpital de la Miletrie, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France., Labouré G; Centre Hospitalier Robert Boulin, Hématologie, Libourne, France., Lionne-Huyghe P; CH d'Arras, Unité d'Hématologie Clinique, Arras, France., Bonnet A; CH de Bretagne Atlantique - Hopital Chubert, Service Hématologie, Vannes, France., Leyronnas C; Union Mutualiste de la Gestion des Eaux Claires, Service Hématologie, Grenoble, France., Guieze R; CHU Estaing, Service Thérapie Cellulaire et Hématologie Clinique, Clermont-Ferrand, France., Launay V; CH Yves Le Foll, Service Hématologie, Saint-Brieuc, France., Drenou B; GH Region Mulhouse et Sud Alsace - Hopital Emile Muller, Service hématologie, Mulhouse, France., Fitoussi O; Polyclinique Bordeaux Nord Aquitaine, Service d'Hémato-Onco Radiothérapie, Bordeaux, France., Detourmignies L; CH De Roubaix - Hopital Victor Provo, Service d'hématologie Clinique, Roubaix, France., Soussain C; Institut Curie - Site Saint-Cloud, Service Hématologie, Saint-Cloud, France., Lachenal F; CH Pierre Oudot, Hématologie, Bourgoin-Jallieu, France., Pica GM; CH Metropole Savoie - Site Chambery, Service Hématologie, Chambery, France., Bernier A; LYSARC, Hôpital Lyon Sud, Pierre Bénite, France., Charton E; Centre Léon Bérard, Human and Social Sciences Department, Lyon, France., Ghesquieres H; Hôpital Lyon Sud, Hématologie, Pierre-Benite, France.

المصدر: Hematological oncology [Hematol Oncol] 2023 Jun; Vol. 41 Suppl 2, pp. 428-429.

نوع المنشور: Congress; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma*/therapy, Humans ; Switzerland ; Congresses as Topic

المؤلفون: Camus V; Centre Henri Becquerel, Department of Hematology, Rouen, France., Thieblemont C; CHU St Louis, Hematology, Paris, France., Gaulard P; University Hospital Henri Mondor, Department of Pathology and InsermU955, Créteil, France, France., Cheminant M; Hopital Universitaire Necker Enfants Malades, Service d'Hematologie adultes, Paris, France., Casasnovas R; Dijon University Hospital, Hematology, Dijon, France., Ysebaert L; IUCT Oncopole, Hematology, Toulouse, France., Damaj GL; CHU de Caen Normandie, Department of Hematology, Caen, France., Guidez S; CHU de Poitiers, Service d'Hématologie, Poitiers, France., Pica GM; Centre Hospitalier Métropole Savoie Chambéry, Department of Hematology, Chambéry, France., Kim WS; Samsung Medical Center, Seoul, Korea., Lim ST; National Cancer Centre Singapore, Singapore, Singapore., Andre M; CHU UCL Namur, Department of Hematology, Yvoir, Belgium., Gutiérrez N; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Penarrubia MJ; Hospital Clinico Universitario de Valladolid, Valladolid, Spain., Staber PB; Medical University Vienna, Division of Hematology, Department of Medicine I, Vienna, Austria., Trotman J; Concord Repatriation General Hospital, University of Sydney, Concord, Australia., Hüttmann A; West German Cancer Center Essen, University Hospital Essen, University of Duisburg-Essen, Department of Hematology and Stem Cell Transplantation, Essen, Germany., Stefoni V; Policlinico Sant'Orsola-Malpighi, Bologna, Italy., Rossi G; Spedali Civili di Brescia, Hematology Division, Brescia, Italy., Delfau-Larue M; University Hospital Henri Mondor, Department of Immunobiology and InsermU955, Créteil, France., Cottereau A; Cochin Hospital, AP-HP, Paris Cité University, Department of Nuclear Medicine, Paris, France., Itti E; CHU Henri Mondor, Department of Nuclear Medicine, Créteil, France., Li J; Bristol Myers Squibb Company, Princeton, USA., Delarue R; Hopital Universitaire Necker Enfants Malades, Service d'Hematologie adultes, Paris, France., de Leval L; Lausanne University Hospital and Lausanne University, Institute of Pathology, Lausanne, Switzerland., Morschhauser F; Univ. Lille, CHU Lille, ULR 7365, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France., Bachy E; Hospices Civils De Lyon, Lyon, France.

المصدر: Hematological oncology [Hematol Oncol] 2023 Jun; Vol. 41 Suppl 2, pp. 77-78.

نوع المنشور: Congress; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma*/therapy, Humans ; Switzerland ; Congresses as Topic

المؤلفون: Morschhauser F; University of Lille, CHU Lille, Lille, France., Nastoupil L; The University of Texas MD Anderson Cancer Center, Houston, TX., Feugier P; Nancy University Hospital, Vandoeuvre-lès-Nancy, France., Schiano de Colella JM; Institut Paoli Calmettes, CRCM, AMU, Marseille, France., Tilly H; Centre Henri Becquerel, Rouen, France., Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY., Bachy E; Hospices Civils de Lyon and Claude Bernard Lyon 1 Université, Lyon, France., Fruchart C; CH de Dunkerque, Dunkerque, France., Libby EN; University of Washington, Seattle, WA., Casasnovas RO; CHU Dijon-Bourgogne, Dijon, France., Flinn IW; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN., Haioun C; Henri Mondor Université Hôpital, UPEC, Créteil, France., Maisonneuve H; Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France., Ysebaert L; Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Bartlett NL; Washington University School of Medicine, St Louis, MO., Bouabdallah K; Bordeaux University Hospital, Bordeaux, France., Brice P; Hôpital Saint-Louis, Paris, France., Ribrag V; Institut Gustave Roussy, Villejuif, France., Le Gouill S; Institut Curie, Paris, France., Daguindau N; Annecy Hôpital, Annecy, France., Guidez S; CHU de Poitiers, Poitiers, France., Pica GM; Centre Hospitalier Métropole Savoie Chambéry, Chambéry, France., García-Sancho AM; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., López-Guillermo A; Hospital Clínic de Barcelona, Barcelona, Spain., Larouche JF; CHU de Québec, Québec, Canada., Ando K; Tokai University School of Medicine, Kanagawa, Japan., Gomes da Silva M; Instituto Português de Oncologia de Lisboa, Lisboa, Portugal., André M; CHU UCL Namur, Yvoir, Belgium., Kalung W; ZNA Stuivenberg, Antwerp, Belgium., Sehn LH; BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada., Izutsu K; National Cancer Center Hospital, Tokyo, Japan., Cartron G; CHU Montpellier, Montpellier, France., Gkasiamis A; Bristol Myers Squibb, Princeton, NJ., Crowe R; Bristol Myers Squibb, Princeton, NJ., Xerri L; Institut Paoli Calmettes, CRCM, AMU, Marseille, France., Fowler NH; The University of Texas MD Anderson Cancer Center, Houston, TX., Salles G; Memorial Sloan Kettering Cancer Center, New York, NY.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Oct 01; Vol. 40 (28), pp. 3239-3245. Date of Electronic Publication: 2022 Aug 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Follicular* , Neoplasms, Second Primary*/etiology, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Humans ; Lenalidomide/therapeutic use ; Rituximab ; Survival Rate